News from transition therapeutics inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 08, 2014, 16:35 ET

Transition Therapeutics to Present at the Oppenheimer 25th Annual Healthcare Conference

TORONTO, Dec. 8, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that Dr....

Nov 24, 2014, 06:01 ET

Transition Therapeutics' ELND005 Showed No Prolongation of QT Interval

TORONTO, Nov. 24, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX:TTH) today announced results...

Nov 20, 2014, 06:01 ET

Transition Therapeutics Announces Results from ELND005 Clinical Study in Adults with Down Syndrome

TORONTO, Nov. 20, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced the...

Nov 12, 2014, 16:01 ET

Transition Therapeutics Announces First Quarter Fiscal 2015 Financial Results

TORONTO, Nov. 12, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a...

Nov 10, 2014, 06:01 ET

Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2015 Financial Results on Wednesday, November 12th, at 4:30 P.M. EST

TORONTO, Nov. 10, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a conference...

Nov 04, 2014, 06:01 ET

Transition Therapeutics Reports Findings from Bipolar Disorder Phase 2 Study

TORONTO, Nov. 4, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced findings...

Sep 25, 2014, 16:01 ET

Transition Therapeutics Announces Fiscal 2014 Year End Financial Results

TORONTO, Sept. 25, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a biopharmaceutical...

Sep 22, 2014, 06:01 ET

Transition Therapeutics to Hold Conference Call on Full Year Fiscal 2014 Financial Results on Thursday, September 25th, at 4:30 P.M. EST

TORONTO, Sept. 22, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a...

Sep 05, 2014, 06:01 ET

Transition Therapeutics to Present at the 16th Annual Rodman & Renshaw Global Investment Conference

TORONTO, Sept. 5, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that...

Jul 11, 2014, 06:01 ET

Transition Therapeutics Appoints Carl Damiani as Chief Operating Officer

TORONTO, July 11, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) Chairman and Chief...

Jun 23, 2014, 06:01 ET

Transition Therapeutics Announces Closing of Private Placement Equity Financing

TORONTO, June 23, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI) (TSX: TTH) announced that it has...

Jun 06, 2014, 09:01 ET

Transition Therapeutics Enters Into a Private Placement with Investors to Receive up to US$30.8 Million in Equity Financing

Company to Receive Upfront US$17 Million Upon Closing TORONTO, June 6, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the...

May 27, 2014, 08:01 ET

Transition Therapeutics to Host Investor Day and Webcast on May 28th in New York City

Live Webcast Beginning at 8am Eastern Time on May 28th TORONTO, May 27, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the...

May 22, 2014, 16:45 ET

Transition Therapeutics to Present at Jefferies 2014 Global Healthcare Conference

TORONTO, May 22, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that...

May 15, 2014, 06:01 ET

Transition Therapeutics Diabetes Drug Candidate, TT-401, Commences Phase 2 Clinical Study

TORONTO, May 15, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced the...

May 13, 2014, 16:01 ET

Transition Therapeutics Announces Third Quarter Fiscal 2014 Financial Results

TORONTO, May 13, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a product-focused...

May 12, 2014, 06:30 ET

Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2014 Financial Results on Tuesday, May 13th, at 4:30 P.M. EST

TORONTO, May 12, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a conference...

Apr 15, 2014, 12:11 ET

Transition Therapeutics Announces No Material Change

TORONTO, April 15, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) reports today that...

Apr 07, 2014, 06:30 ET

Transition Therapeutics Announces Development Update

TORONTO, April 7, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI) (TSX: TTH) provided an update on...

Mar 03, 2014, 13:15 ET

Transition Therapeutics to Present at the 34th Annual Cowen & Co. Healthcare Conference

TORONTO, March 3, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI) (TSX: TTH) announced today that...